1. Home
  2. CTMX vs GRWG Comparison

CTMX vs GRWG Comparison

Compare CTMX & GRWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • GRWG
  • Stock Information
  • Founded
  • CTMX 2008
  • GRWG 2008
  • Country
  • CTMX United States
  • GRWG United States
  • Employees
  • CTMX N/A
  • GRWG N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • GRWG RETAIL: Building Materials
  • Sector
  • CTMX Health Care
  • GRWG Consumer Discretionary
  • Exchange
  • CTMX Nasdaq
  • GRWG Nasdaq
  • Market Cap
  • CTMX 62.3M
  • GRWG 82.3M
  • IPO Year
  • CTMX 2015
  • GRWG N/A
  • Fundamental
  • Price
  • CTMX $0.80
  • GRWG $1.43
  • Analyst Decision
  • CTMX Buy
  • GRWG Hold
  • Analyst Count
  • CTMX 6
  • GRWG 5
  • Target Price
  • CTMX $5.77
  • GRWG $2.75
  • AVG Volume (30 Days)
  • CTMX 731.5K
  • GRWG 631.1K
  • Earning Date
  • CTMX 03-10-2025
  • GRWG 03-12-2025
  • Dividend Yield
  • CTMX N/A
  • GRWG N/A
  • EPS Growth
  • CTMX N/A
  • GRWG N/A
  • EPS
  • CTMX 0.16
  • GRWG N/A
  • Revenue
  • CTMX $126,617,000.00
  • GRWG $200,882,000.00
  • Revenue This Year
  • CTMX $22.55
  • GRWG N/A
  • Revenue Next Year
  • CTMX N/A
  • GRWG N/A
  • P/E Ratio
  • CTMX $4.93
  • GRWG N/A
  • Revenue Growth
  • CTMX 33.66
  • GRWG N/A
  • 52 Week Low
  • CTMX $0.75
  • GRWG $1.35
  • 52 Week High
  • CTMX $5.85
  • GRWG $3.38
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 41.61
  • GRWG 45.07
  • Support Level
  • CTMX $0.75
  • GRWG $1.35
  • Resistance Level
  • CTMX $0.98
  • GRWG $1.58
  • Average True Range (ATR)
  • CTMX 0.06
  • GRWG 0.08
  • MACD
  • CTMX 0.00
  • GRWG 0.01
  • Stochastic Oscillator
  • CTMX 20.13
  • GRWG 34.78

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About GRWG GrowGeneration Corp.

GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, advanced indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.

Share on Social Networks: